Videos
Video
Physician-Scientist Marco Davila, MD, PhD, Joins Growing Roswell Park Cellular Therapy Program
Following a national search, Roswell Park Comprehensive Cancer Center has appointed Marco Davila, MD, PhD, as Senior Vice President and Associate Director for Translational Research and Vice-Chair for Cellular Therapies.
Video
Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy
Roswell Park Comprehensive Cancer Center is the first center to treat patients in a newly opened advanced-stage clinical trial utilizing the brain cancer vaccine SurVaxM, offering a new treatment option for patients who are dealing with ...
Video
Roswell Park Neuro-Oncology Team Expands with Specially Trained Surgeon
Meet Lindsay Lipinski, MD, FAANS. Dr. Lipinski brings exertise in peripheral nerve tumors and entrapment neuropathies to the Roswell Park Neuro-Oncology Team.
News
News
Clinical Trial of Roswell Park’s SurVaxM Glioblastoma Vaccine Reveals Promising Results
Clinical Trial of Roswell Park’s SurVaxM Glioblastoma Vaccine Reveals Promising Results.
News
Roswell Park Comprehensive Cancer Center Professor of Neurosurgery Michael Ciesielski, PhD, presented the most recent findings from the completed phase 2A study of the immunotherapy SurVaxM at a poster session in June at the American Society ...
News
Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy
First center to treat newly diagnosed glioblastoma patients as part of late-stage trial with SurVaxM
News
The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM.
Download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.
BROADCASTMED